JPH0336493B2 - - Google Patents
Info
- Publication number
- JPH0336493B2 JPH0336493B2 JP57146252A JP14625282A JPH0336493B2 JP H0336493 B2 JPH0336493 B2 JP H0336493B2 JP 57146252 A JP57146252 A JP 57146252A JP 14625282 A JP14625282 A JP 14625282A JP H0336493 B2 JPH0336493 B2 JP H0336493B2
- Authority
- JP
- Japan
- Prior art keywords
- acid
- fatty acids
- eggs
- feed
- omega
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 235000013601 eggs Nutrition 0.000 claims description 30
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims description 27
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 20
- 150000002148 esters Chemical class 0.000 claims description 16
- 244000144977 poultry Species 0.000 claims description 12
- 229930003427 Vitamin E Natural products 0.000 claims description 10
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 10
- 235000021122 unsaturated fatty acids Nutrition 0.000 claims description 10
- 150000004670 unsaturated fatty acids Chemical class 0.000 claims description 10
- 235000019165 vitamin E Nutrition 0.000 claims description 10
- 229940046009 vitamin E Drugs 0.000 claims description 10
- 239000011709 vitamin E Substances 0.000 claims description 10
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 claims description 9
- 235000013402 health food Nutrition 0.000 claims description 9
- 235000020778 linoleic acid Nutrition 0.000 claims description 9
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims description 9
- 102000002322 Egg Proteins Human genes 0.000 claims description 8
- 108010000912 Egg Proteins Proteins 0.000 claims description 8
- 235000013345 egg yolk Nutrition 0.000 claims description 8
- 210000002969 egg yolk Anatomy 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 6
- SBHCLVQMTBWHCD-METXMMQOSA-N (2e,4e,6e,8e,10e)-icosa-2,4,6,8,10-pentaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C(O)=O SBHCLVQMTBWHCD-METXMMQOSA-N 0.000 claims description 5
- PIFPCDRPHCQLSJ-WYIJOVFWSA-N 4,8,12,15,19-Docosapentaenoic acid Chemical compound CC\C=C\CC\C=C\C\C=C\CC\C=C\CC\C=C\CCC(O)=O PIFPCDRPHCQLSJ-WYIJOVFWSA-N 0.000 claims description 5
- PIFPCDRPHCQLSJ-UHFFFAOYSA-N Clupanodonic acid Natural products CCC=CCCC=CCC=CCCC=CCCC=CCCC(O)=O PIFPCDRPHCQLSJ-UHFFFAOYSA-N 0.000 claims description 5
- HXWJFEZDFPRLBG-UHFFFAOYSA-N Timnodonic acid Natural products CCCC=CC=CCC=CCC=CCC=CCCCC(O)=O HXWJFEZDFPRLBG-UHFFFAOYSA-N 0.000 claims description 5
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims description 5
- 229940090949 docosahexaenoic acid Drugs 0.000 claims description 5
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 claims description 5
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 claims description 3
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims description 2
- MBMBGCFOFBJSGT-SFGLVEFQSA-N docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C\C\C=C\C\C=C\C\C=C\C\C=C\C\C=C\CCC(O)=O MBMBGCFOFBJSGT-SFGLVEFQSA-N 0.000 claims 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 claims 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 16
- 235000021323 fish oil Nutrition 0.000 description 10
- 235000013594 poultry meat Nutrition 0.000 description 10
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 241000700159 Rattus Species 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 241000251468 Actinopterygii Species 0.000 description 3
- 239000003925 fat Substances 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 235000019688 fish Nutrition 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 241000238366 Cephalopoda Species 0.000 description 2
- 241000555825 Clupeidae Species 0.000 description 2
- 241000442132 Lactarius lactarius Species 0.000 description 2
- 241001290266 Sciaenops ocellatus Species 0.000 description 2
- 241000269821 Scombridae Species 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000020640 mackerel Nutrition 0.000 description 2
- 235000014593 oils and fats Nutrition 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 235000019512 sardine Nutrition 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229940013317 fish oils Drugs 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Description
本発明は健康食品卵、更に詳細には、５，８，
11，14，17−エイコサペンタエン酸、４，８，
12，15，19−ドコサペンタエン酸及び４，７，
10，13，16，19−ドコサヘキサエン酸あるいはこ
れと更にリノール酸又は（及び）ビタミンＥを含
有する血中コレステロールの上昇を抑制する健康
食品卵の生産方法に関する。
卵は栄養価が高く、バランスのとれた栄養成分
が含まれた優れた食品であるが、コレステロール
含量が高いので、その摂取量を制限しなければな
らない。そこで、近年卵中に種々の薬剤を含有せ
しめて血中コレステロールの上昇を抑制しようと
いう研究が行われ、多くの報告がなされている。
一方、天然油脂、例えばサバ、イワシ、等の多
獲性赤身魚、タラ等の多獲性白身魚及びイカ類の
魚油中に含まれているω3系高度不飽和脂肪酸が
血中コレステロールを減少させる作用を現するこ
とが報告され（例えば特開昭54−154533号参照）
て以来、これを血栓症等の治療予防剤として使用
せんとする研究が盛んになつてきた。
しかし、新鮮魚体中に含まれる油脂量は５〜20
重量％（以下単に％として示す）であり、該油脂
中に含有する「５，８，11，14，17−エイコサペ
ンタエン酸（C20:5）、４，７，10，13，16，19
−ドコサヘキサエン酸（C22:6）等のω3系高度
不飽和脂肪酸は15〜30％であるため、新鮮魚体中
にはω3系高度不飽和脂肪酸が１〜６％程度した
存在しない。しかも、ω3系高度不飽和脂肪酸は
極めて不安定な化合物であり、食品加工等により
分解されやすい性質のものである。更に、近年、
食生活の変化に伴い、新鮮多獲性魚類の摂取量が
減少する傾向にある、従つて、ω3系高度不飽和
脂肪酸を一般の食生活から摂取することは困難な
状況にある。
一方、魚油として食用に供することは、魚臭が
著しく嗜好面での実用性に劣る。
また、ω3系高度不飽和脂肪酸を薬剤とするに
は、天然油脂から単離する乃至は高濃度に濃縮す
ることが必要であるが、前記のように不安定な化
合物であり、また天然油脂中には当該不飽和脂肪
酸と構造及び物性が近似する脂肪酸が多量に含ま
れているため、ω3系高度不飽和脂肪酸を高濃度
で得るためには多大の経費と労力を必要とする。
斯かる実情において、本発明者は鋭意研究を行
つた結果、ω3系高度不飽和脂肪酸又はそのエス
テルを含有する飼料を採卵用家禽に与えて飼育す
れば、ω3系高度不飽和脂肪酸を多量に含む卵が
生産されることを見出し、本発明を完成した。
すなわち、本願の第一の発明は、採卵用家禽
に、５，８，11，14，17−エイコサペンタエン
酸、４，８，12，15，19−ドコサペンタエン酸及
び４，７，10，13，16，19−ドコサヘキサエン酸
より選ばれるω3系高度不飽和脂肪酸又はそのエ
ステルの１種又は２種以上を含む魚油又は魚油エ
ステルを含有する飼料を与えて飼育して健康食品
卵を生産する方法である。
本発明方法において、飼料に配合されるω3系
高度不飽和脂肪酸又はそのエステルは純品であつ
ても、またこれを含むものであつてもよいが、一
般には天然油脂（サバ、イワシ等の多獲性赤身
魚、タラ等の多獲性白身魚及びイカ類の魚油）、
またはこれを常法に従つてケン化したもの、ある
いは更にメチルまたはエチルエステル化した魚油
エステルが好ましい。魚油または魚油エステル
は、ゼラチン−糖アルコール−水等の乳化剤を使
用して乳化物の形態にして与えると、魚臭も少な
く、また卵黄へのω3系高度不飽和脂肪酸の移行
効率もよく更に好ましい。
ω3系高度不飽和脂肪酸又はそのエステルの飼
料中への配合量は、0.1〜５％になるようにする
のが好ましく、魚油又は魚油エステルの場合に
は、飼料１Kg当り５〜100ｇ配合するのが好まし
い。このような飼料を８日間以上与えるとω3系
高度不飽和脂肪酸を多量、例えば卵黄100ｇ当り
0.5ｇ以上を含む卵が生産される。飼料へのω3系
高度不飽和脂肪酸又はそのエステル配合量が0.1
％未満では卵黄100ｇ当り0.5ｇ以上のω3系高度
不飽和脂肪酸を含む卵が得られず、また配合量が
５％を越えても卵黄中のω3系高度不飽和脂肪酸
量はこれ以上増加しない。
更にまた、本発明者は、上記のω3系高度不飽
和脂肪酸又はそのエステルを含む飼料に更にリノ
ール酸又は（及び）ビタミンＥを配合したものを
家禽に与えて飼育すると、リノール酸及びビタミ
ンＥを含む卵が生産され、これらによつてω3系
高度不飽和脂肪酸による血中コレステロール低下
作用が増強されることを見出した。
従つて、本願の第二の発明は、採卵用家禽に上
記ω3系高度不飽和脂肪酸又はそのエステル並び
にリノール酸又は（及び）ビタミンＥを含有する
飼料を与えて飼育して健康食品卵を生産する方法
である。
ここで使用されるリノール酸はそれ自体でも又
これを含むものでもよく、例えばこの含有量の多
い大豆油、サフラワー油等の植物油が一般に使用
される。リノール酸、ビタミンＥの配合量は、飼
料中にそれぞれ１〜10％、0.02〜１％になるよう
にするのが好ましい。
叙上の如くして本発明方法で生産される健康食
品卵は多量のω3系高度不飽和脂肪酸、リノール
酸、ビタミンＥを含んでいるので、これを摂取す
ると血中コレステロールを低下させ、高血圧、血
栓症を予防ないし治療することができると共に、
卵の摂取による高コレステロールを防止できる。
次に実施例を挙げて説明する。
実施例 １
第１表に示す組成の飼料を調製し、各区100羽
の家禽に自由給飼させて飼育し、８日目に産卵し
た卵について、卵黄中のω3系高度不飽和脂肪酸
量を測定した。
The present invention relates to health food eggs, more specifically, 5, 8,
11,14,17-eicosapentaenoic acid, 4,8,
12,15,19-docosapentaenoic acid and 4,7,
The present invention relates to a method for producing a health food egg containing 10, 13, 16, 19-docosahexaenoic acid or linoleic acid or/and vitamin E, which suppresses the rise in blood cholesterol. Eggs are a highly nutritious and well-balanced food, but their intake must be limited due to their high cholesterol content. Therefore, in recent years, research has been conducted to suppress the rise in blood cholesterol by incorporating various drugs into eggs, and many reports have been made. On the other hand, natural oils and fats, such as omega-3 polyunsaturated fatty acids contained in fish oils from high-catch red fish such as mackerel and sardines, high-catch white fish such as cod, and squid, reduce blood cholesterol. It has been reported that this effect appears (for example, see JP-A-54-154533).
Since then, there has been active research into using it as a therapeutic and preventive agent for thrombosis, etc. However, the amount of oil and fat contained in fresh fish is 5 to 20.
5,8,11,14,17-eicosapentaenoic acid ( C20 : 5 ), 4,7,10,13,16,19 contained in the oil and fat (hereinafter simply expressed as %).
- Since ω3 polyunsaturated fatty acids such as docosahexaenoic acid (C 22 : 6 ) account for 15 to 30%, fresh fish do not contain approximately 1 to 6% ω3 polyunsaturated fatty acids. Furthermore, omega-3 highly unsaturated fatty acids are extremely unstable compounds and are easily decomposed during food processing. Furthermore, in recent years,
With changes in dietary habits, the amount of freshly caught fish tends to decrease, making it difficult to intake omega-3 polyunsaturated fatty acids from the general diet. On the other hand, when used as fish oil for human consumption, it has a very fishy odor and is not practical in terms of taste. In addition, in order to use omega-3 highly unsaturated fatty acids as a drug, it is necessary to isolate them from natural fats and oils or concentrate them to a high concentration, but as mentioned above, they are unstable compounds, and contains a large amount of fatty acids whose structure and physical properties are similar to those of the unsaturated fatty acids, so it requires a great deal of expense and effort to obtain ω3-based highly unsaturated fatty acids at high concentrations. Under these circumstances, the present inventor conducted extensive research and found that if poultry for egg production is fed and reared with feed containing ω3 polyunsaturated fatty acids or their esters, they will contain a large amount of ω3 polyunsaturated fatty acids. They discovered that eggs can be produced and completed the present invention. That is, the first invention of the present application provides poultry for egg collection with 5,8,11,14,17-eicosapentaenoic acid, 4,8,12,15,19-docosapentaenoic acid and 4,7,10, A method for producing health food eggs by feeding and raising feed containing fish oil or fish oil ester containing one or more of omega-3 polyunsaturated fatty acids selected from 13, 16, 19-docosahexaenoic acids or esters thereof It is. In the method of the present invention, the omega-3 highly unsaturated fatty acids or their esters added to the feed may be pure or contain them, but generally natural oils and fats (mackerel, sardines, etc.) (Fish oil from prey red fish, white fish such as cod, and squid),
Alternatively, a fish oil ester obtained by saponifying this in accordance with a conventional method, or a fish oil ester obtained by further converting it into a methyl or ethyl ester is preferable. It is more preferable to provide fish oil or fish oil ester in the form of an emulsion using an emulsifier such as gelatin-sugar alcohol-water, which has less fishy odor and improves the efficiency of transfer of omega-3 polyunsaturated fatty acids to egg yolk. . The amount of omega-3 highly unsaturated fatty acids or their esters added to the feed is preferably 0.1 to 5%, and in the case of fish oil or fish oil esters, it is recommended to add 5 to 100 g per 1 kg of feed. preferable. If such feed is fed for more than 8 days, it will contain a large amount of omega-3 polyunsaturated fatty acids, for example, per 100g of egg yolk.
Eggs containing more than 0.5g are produced. The amount of omega-3 polyunsaturated fatty acids or their esters added to feed is 0.1
If the amount is less than 5%, eggs containing 0.5 g or more of ω3 polyunsaturated fatty acids per 100 g of egg yolk cannot be obtained, and even if the amount exceeds 5%, the amount of ω3 polyunsaturated fatty acids in the egg yolk will not increase any further. Furthermore, the present inventor has discovered that when poultry is fed a feed containing the above-mentioned omega-3 highly unsaturated fatty acid or its ester and linoleic acid or (and) vitamin E is fed to poultry, linoleic acid and vitamin E are increased. It was found that eggs containing omega-3 polyunsaturated fatty acids were produced, and that these enhanced the blood cholesterol-lowering effect of omega-3 polyunsaturated fatty acids. Therefore, the second invention of the present application is to feed poultry for egg collection with feed containing the above-mentioned ω3-based polyunsaturated fatty acids or their esters, linoleic acid or (and) vitamin E, and raise them to produce health food eggs. It's a method. The linoleic acid used here may be itself or one containing linoleic acid; for example, vegetable oils containing a large amount of linoleic acid, such as soybean oil and safflower oil, are generally used. The amounts of linoleic acid and vitamin E added in the feed are preferably 1-10% and 0.02-1%, respectively. As mentioned above, the health food egg produced by the method of the present invention contains a large amount of omega-3 polyunsaturated fatty acids, linoleic acid, and vitamin E, so when ingested, it lowers blood cholesterol, high blood pressure, and In addition to being able to prevent or treat thrombosis,
High cholesterol caused by egg intake can be prevented. Next, an example will be given and explained. Example 1 A feed with the composition shown in Table 1 was prepared, 100 poultry in each group were fed ad libitum, and the amount of ω3 polyunsaturated fatty acids in the egg yolk was measured for eggs laid on the 8th day. did.
【表】 その結果は第２表のとおりである。【table】 The results are shown in Table 2.
【表】
実施例 ２
第３表に示す組成の飼料を調製し、これを用い
て実施例１と同様にして家禽を飼育し、ω3系高
度不飽和脂肪酸量を測定した。[Table] Example 2 A feed having the composition shown in Table 3 was prepared, and poultry was raised in the same manner as in Example 1 using this feed, and the amount of ω3 polyunsaturated fatty acids was measured.
【表】 その結果は第４表のとおりである。【table】 The results are shown in Table 4.
【表】
実施例 ３
第５表に示す組成の飼料を調製し、実施例１と
同様にして家禽を飼育し、８日目に産卵した卵に
ついて、卵黄中のω3系高度不飽和脂肪酸、リノ
ール酸及びビタミンＥの量を測定した。[Table] Example 3 A feed having the composition shown in Table 5 was prepared, poultry was raised in the same manner as in Example 1, and eggs laid on the 8th day were examined for ω3 polyunsaturated fatty acids and linole in the egg yolk. The amounts of acid and vitamin E were measured.
【表】
その結果は第６表のとおりである。
[Table] The results are shown in Table 6.
【表】
実施例 ４
() 第７表に示す組成の飼料を調製し、これを
用いて家禽を飼育し、８日目に産卵した卵を凍
結乾燥して全卵粉とした。[Table] Example 4 () A feed having the composition shown in Table 7 was prepared, poultry was raised using the feed, and eggs laid on the 8th day were freeze-dried to obtain whole egg powder.
【表】
() で得た全卵粉を用いて第８表に示すラツ
ト用飼料を調製した。[Table] Using the whole egg powder obtained in (), the rat feed shown in Table 8 was prepared.
【表】【table】
【表】
() 体重約100ｇのラツト（一群８〜９匹）に
で得たラツト用飼料を自由摂食法（１日10〜
15ｇ）で与えて飼育し、１ケ月後における血漿
コレステロールを酸素法により測定した。その
結果は第９表のとおりである。[Table] () Rats weighing approximately 100 g (8 to 9 rats per group) were given ad libitum feeding method (10 to 9 rats per day).
After one month, plasma cholesterol was measured by oxygen method. The results are shown in Table 9.
【表】
第９表から明らかな如く、本発明のω3系高度
不飽和脂肪酸含有卵には血漿コレステロールの上
昇を抑制する効果認められ、更にリノール酸及び
ビタミンＥを含む卵では当該作用が増強される。
実施例 ５
第10表に示す組成の飼料を調製し、各区100羽
の家禽に自由給飼させて飼育し、８日目に産卵し
た卵について、卵黄中のω3系高度不飽和脂肪酸
量を測定した。[Table] As is clear from Table 9, eggs containing omega-3 polyunsaturated fatty acids of the present invention have the effect of suppressing the rise in plasma cholesterol, and eggs containing linoleic acid and vitamin E further enhance this effect. Ru. Example 5 Feed with the composition shown in Table 10 was prepared, 100 poultry in each group were fed ad libitum, and the amount of ω3 polyunsaturated fatty acids in the egg yolk was measured for eggs laid on the 8th day. did.
【表】【table】
【表】【table】
Claims (1)
サペンタエン酸、４，８，12，15，19−ドコサペ
ンタエン酸及び４，７，10，13，16，19−ドコサ
ヘキサエン酸より選ばれるω3系高度不飽和脂肪
酸又はそのエステルの１種又は２種以上を含む魚
油又は魚油エステルを含有する飼料を与えて飼育
することを特徴とする健康食品卵の生産方法。 ２ 飼料中に該ω3系高度不飽和脂肪酸又はその
エステルをその合計量で0.1〜５重量％含有し、
健康食品卵が卵黄100ｇ当り５，８，11，14，17
−エイコサペンタエン酸、４，８，12，15，19−
ドコサペンタエン酸及び４，７，10，13，16，19
−ドコサヘキサエン酸より選ばれるω3系高度不
飽和脂肪酸の１種又は２種以上をその合計量で
0.5ｇ以上含有するものである特許請求の範囲第
１項記載の健康食品卵の生産方法。 ３ 採卵用家禽に、５，８，11，14，17−エイコ
サペンタエン酸、４，８，12，15，19−ドコサペ
ンタエン酸及び４，７，10，13，16，19−ドコサ
ヘキサエン酸より選ばれるω3系高度不飽和脂肪
酸又はそのエステルの１種又は２種以上並びにリ
ノール酸又は（及び）ビタミンＥを含有する飼料
を与えて飼育することを特徴とする健康食品卵の
生産方法。 ４ 飼料中に、該ω3系高度不飽和脂肪酸又はそ
のエステルを合計量で0.1〜５重量％、リノール
酸を0.5〜５重量％、ビタミンＥを0.02〜１重量
％含有する特許請求の範囲第３項記載の健康食品
卵の生産方法。[Scope of Claims] 1. 5,8,11,14,17-eicosapentaenoic acid, 4,8,12,15,19-docosapentaenoic acid and 4,7,10,13,16 in poultry for egg collection. , 19-docosahexaenoic acid, or 19-docosahexaenoic acid, or esters thereof. . 2. The total amount of the ω3-based highly unsaturated fatty acid or its ester is contained in the feed in an amount of 0.1 to 5% by weight,
Health food eggs: 5, 8, 11, 14, 17 per 100g of egg yolk
-Eicosapentaenoic acid, 4,8,12,15,19-
Docosapentaenoic acid and 4,7,10,13,16,19
-The total amount of one or more omega-3 highly unsaturated fatty acids selected from docosahexaenoic acid
The method for producing a health food egg according to claim 1, which contains 0.5g or more. 3. From 5,8,11,14,17-eicosapentaenoic acid, 4,8,12,15,19-docosapentaenoic acid and 4,7,10,13,16,19-docosahexaenoic acid to poultry for egg collection. A method for producing eggs as a health food, which comprises raising eggs with feed containing one or more selected omega-3 polyunsaturated fatty acids or esters thereof, and linoleic acid or/and vitamin E. 4 Claim 3, wherein the feed contains 0.1 to 5% by weight of the ω3 highly unsaturated fatty acid or its ester, 0.5 to 5% by weight of linoleic acid, and 0.02 to 1% by weight of vitamin E. Method for producing health food eggs as described in Section 1.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57146252A JPS5939258A (en) | 1982-08-25 | 1982-08-25 | Production of health food egg |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57146252A JPS5939258A (en) | 1982-08-25 | 1982-08-25 | Production of health food egg |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5939258A JPS5939258A (en) | 1984-03-03 |
| JPH0336493B2 true JPH0336493B2 (en) | 1991-05-31 |
Family
ID=15403532
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP57146252A Granted JPS5939258A (en) | 1982-08-25 | 1982-08-25 | Production of health food egg |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5939258A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996038051A1 (en) * | 1995-05-30 | 1996-12-05 | Suntory Limited | Fowl eggs with high content of highly unsaturated fatty acids, process for producing the same, and use thereof |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3719097C1 (en) * | 1987-06-06 | 1988-06-09 | Fratzer Uwe | Medicament containing eicosapentaenoic acid and docosahexaenoic acid as unsaturated fatty acids as well as vitamin E. |
| US5133963A (en) * | 1990-12-21 | 1992-07-28 | Shuntaro Ise | Method of producing commercially useful poultry products with increased concentrations of Omega-3 polyunsaturated fatty acids |
| FR2749133A1 (en) * | 1996-06-04 | 1997-12-05 | Pierre Moreau | Production of phospholipid(s) which are rich in docosahexaenoic acid |
| US6579551B1 (en) | 1998-05-21 | 2003-06-17 | Beech-Nut Nutrition Corporation | Baby-food compositions containing egg yolk and methods therefor |
| US6149964A (en) * | 1998-05-21 | 2000-11-21 | Beech-Nut Nutrition Corporation | Egg yolk-containing baby food compositions and methods therefor |
| US7413759B2 (en) | 1998-05-21 | 2008-08-19 | Beech-Nut Nutrition Corporation | Method of enhancing cognitive ability in infant fed DHA containing baby-food compositions |
| ATE554177T1 (en) | 2007-06-04 | 2012-05-15 | Univ Hokkaido Nat Univ Corp | METHOD FOR PRODUCING DHA-CONTAINING PHOSPHOLIPIDE BY MICROBIAL FERMENTATION |
| JP6673649B2 (en) * | 2015-06-26 | 2020-03-25 | 株式会社アキタフーズ | Spawning poultry feed |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57115159A (en) * | 1980-12-05 | 1982-07-17 | Kenji Goto | Egg containing high concentration of organic iodine binding with unsaturated fatty acid in lipid |
-
1982
- 1982-08-25 JP JP57146252A patent/JPS5939258A/en active Granted
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57115159A (en) * | 1980-12-05 | 1982-07-17 | Kenji Goto | Egg containing high concentration of organic iodine binding with unsaturated fatty acid in lipid |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996038051A1 (en) * | 1995-05-30 | 1996-12-05 | Suntory Limited | Fowl eggs with high content of highly unsaturated fatty acids, process for producing the same, and use thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5939258A (en) | 1984-03-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hargis et al. | Dietary modification of yolk lipid with menhaden oil | |
| DE69935995T3 (en) | POLYUNGATURATED FATTY ACIDS NUTRITIONAL SUPPLEMENT | |
| DE69731467T2 (en) | PROCESS FOR MAINTAINING EXISTING BODY FAT CONTENT AND / OR BODY WEIGHT | |
| EP0304819B1 (en) | Animal feed supplement | |
| JP2992836B2 (en) | Method for reducing animal body fat by administering conjugated linoleic acid | |
| KR0129666B1 (en) | Essenial fatty acid composition | |
| Newton | Long chain fatty acids in health and nutrition | |
| CA2147302C (en) | A lipid composition for normalizing injury | |
| JPS58189110A (en) | Nutritious lipid composition | |
| EP2027864B1 (en) | Composition for improvement of lipid metabolism | |
| JPH0551271B2 (en) | ||
| Wealleans et al. | Fats and oils in pig nutrition: Factors affecting digestion and utilization | |
| JPH0336493B2 (en) | ||
| AU654803B2 (en) | Process for enrichment of fat with regard to polyunsaturated fatty acids and phospholipids, and application of such enriched fat | |
| DE3739700A1 (en) | Formulations containing alpha -linolenic acid (18:3, omega 3) and/or derivatives thereof, and process for their preparation and use in nutrition and medicine | |
| Ackman | DHA: can it benefit salmon marketing? | |
| JP2006306813A (en) | Mast cell increase inhibitor | |
| JPH0759540A (en) | Arachidonic acid-containing healthy food | |
| US5130147A (en) | Cholesterol lowering colloidal food product containing meat and omega fatty acid and process for preparing | |
| JPS6336744A (en) | Edible oil and fat composition effective in preventing allergy, thrombosis and hypertension | |
| JPH0477600A (en) | Method for obtaining lipid composition containing docosahexaenoic acid in high content | |
| JPH0371100B2 (en) | ||
| WO1993021774A1 (en) | Method of balancing oils and fats to enhance health | |
| JP5735576B2 (en) | Composition containing coenzyme Q10 | |
| JPH01290625A (en) | Cerebral function improver |